Physician profile
Kim Lane
NPI 1477548188
$2,381.92
in general payments reported to CMS, 2019-2025
22 companies · $521 in 2025
The $521 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $160 · 2021: $349 · 2022: $320 · 2023: $469 · 2024: $283 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209 · Education: $64.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.53 |
| Education | $64.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $685.60 | 2021-2025 | |
| Abbvie INC. | $463.23 | 2019-2025 | |
| Baxter Healthcare | $344.91 | 2021-2025 | Tisseel |
| Therapeuticsmd, INC. | $160.58 | 2019-2022 | |
| Pfizer INC. | $129.11 | 2020-2024 | |
| Astellas Pharma US INC | $99.22 | 2023-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $80.96 | 2024-2025 | Myfembree |
| Conmed Corporation | $65.88 | 2020 | |
| Millicent US INC | $63.78 | 2025 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $48.50 | 2019-2024 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $34.12 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $32.69 | 2019-2020 | |
| Avion Pharmaceuticals | $32.30 | 2021-2022 | |
| Meditrina | $19.59 | 2021 | |
| Exeltis, USA INC. | $18.59 | 2024 | Slynd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $18.49 | 2025 | Fornisee |
| Covidien LP | $18.10 | 2019 | |
| Roche Diagnostics Corporation | $14.36 | 2020 | |
| Allergan, INC. | $14.06 | 2019 | |
| Evofem Biosciences, INC. | $13.67 | 2021 | |
| Dysis Medical, INC. | $12.94 | 2021 | |
| Coopersurgical, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.